Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
María José
García Velloso
Consultora Médica
María José García Velloso-rekin lankidetzan egindako argitalpenak (46)
2023
-
Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440
-
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108
2022
-
11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value
International Journal of Molecular Sciences, Vol. 23, Núm. 17
2021
-
Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160
-
Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer
Cancers, Vol. 13, Núm. 14
-
Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma
Physica Medica, Vol. 84, pp. 1-9
2020
-
Article18 f-fdg and11 c-methionine pet/ct in newly diagnosed multiple myeloma patients: Comparison of volume-based pet biomarkers
Cancers, Vol. 12, Núm. 4
-
FDG PET/CT in colorectal cancer
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66
-
The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT
European Journal of Radiology, Vol. 133
2018
-
Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET
BMC Cancer, Vol. 18, Núm. 1
-
Evolution of Nuclear Medicine in the diagnosis and treatment of prostate cancer
Revista Espanola de Medicina Nuclear e Imagen Molecular
-
Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality
Physica Medica, Vol. 46, pp. 134-139
2017
-
11C-Methionine-PET in multiple myeloma: A combined study from two different institutions
Theranostics, Vol. 7, Núm. 11, pp. 2956-2964
-
Effective dose estimation for oncological and neurological PET/CT procedures
EJNMMI Research, Vol. 7, Núm. 1
-
MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer
European Radiology, Vol. 27, Núm. 8, pp. 3190-3198
-
Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury
Journal of Translational Medicine, Vol. 15, Núm. 1
2016
-
Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT
Lung Cancer, Vol. 97, pp. 81-86
2015
-
Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)
Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176
2014
-
Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
European Journal of Nuclear Medicine and Molecular Imaging
-
PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization
Medical Physics, Vol. 41, Núm. 9